RJ Glynn

1.9k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

RJ Glynn is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, RJ Glynn has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in RJ Glynn's work include Pharmacogenetics and Drug Metabolism (2 papers), Alcohol Consumption and Health Effects (2 papers) and Blood Pressure and Hypertension Studies (2 papers). RJ Glynn is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Alcohol Consumption and Health Effects (2 papers) and Blood Pressure and Hypertension Studies (2 papers). RJ Glynn collaborates with scholars based in United States and United Kingdom. RJ Glynn's co-authors include Jerry H. Gurwitz, Mark Monane, Jerry Avorn, R Levin, Rhonda L. Bohn, P. M. Ridker, DL Veenstra, Steven G. E. Marsh, Taimour Langaee and Deepak Voora and has published in prestigious journals such as Blood, American Journal of Epidemiology and American Journal of Public Health.

In The Last Decade

RJ Glynn

19 papers receiving 1.4k citations

Hit Papers

Use of Pharmacogenetic and Clinical Factors to Predict th... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RJ Glynn United States 14 527 355 240 228 184 20 1.4k
Paul E. Milligan United States 18 1.3k 2.4× 1.2k 3.5× 527 2.2× 347 1.5× 167 0.9× 31 2.6k
Hubert G.M. Leufkens Netherlands 23 230 0.4× 422 1.2× 168 0.7× 480 2.1× 198 1.1× 62 3.0k
Gloria R. Grice United States 16 864 1.6× 216 0.6× 339 1.4× 165 0.7× 119 0.6× 31 1.3k
Tom Schalekamp Netherlands 17 1.0k 2.0× 325 0.9× 179 0.7× 212 0.9× 99 0.5× 28 1.7k
Christina L. Aquilante United States 26 829 1.6× 248 0.7× 371 1.5× 94 0.4× 52 0.3× 87 2.3k
Jacques LeLorier Canada 30 126 0.2× 864 2.4× 329 1.4× 341 1.5× 71 0.4× 95 3.3k
Jonatan D. Lindh Sweden 26 1.3k 2.4× 419 1.2× 556 2.3× 167 0.7× 140 0.8× 83 2.9k
Nancy L. Shapiro United States 19 405 0.8× 364 1.0× 158 0.7× 75 0.3× 45 0.2× 51 1.1k
Adam P. Bress United States 26 295 0.6× 1.5k 4.3× 386 1.6× 315 1.4× 87 0.5× 130 2.5k
J. Russell Teagarden United States 15 258 0.5× 309 0.9× 165 0.7× 204 0.9× 43 0.2× 44 1.0k

Countries citing papers authored by RJ Glynn

Since Specialization
Citations

This map shows the geographic impact of RJ Glynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RJ Glynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RJ Glynn more than expected).

Fields of papers citing papers by RJ Glynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RJ Glynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RJ Glynn. The network helps show where RJ Glynn may publish in the future.

Co-authorship network of co-authors of RJ Glynn

This figure shows the co-authorship network connecting the top 25 collaborators of RJ Glynn. A scholar is included among the top collaborators of RJ Glynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RJ Glynn. RJ Glynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneeweiß, Sebastian, et al.. (2011). Understanding Bias Amplification. American Journal of Epidemiology. 4 indexed citations
2.
Peña, José M., Jean MacFadyen, RJ Glynn, & P. M. Ridker. (2011). High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. European Heart Journal. 33(4). 531–537. 95 indexed citations
3.
Lunt, Mark, Daniel H. Solomon, Kenneth J. Rothman, et al.. (2009). Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification. American Journal of Epidemiology. 169(7). 909–917. 70 indexed citations
4.
Gage, Brian F., Charles Eby, JA Johnson, et al.. (2008). Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin. Clinical Pharmacology & Therapeutics. 84(3). 326–331. 595 indexed citations breakdown →
5.
Rassen, Jeremy A., Sebastian Schneeweiß, RJ Glynn, Murray A. Mittleman, & M. Alan Brookhart. (2008). Instrumental Variable Analysis for Estimation of Treatment Effects With Dichotomous Outcomes. American Journal of Epidemiology. 169(3). 273–284. 114 indexed citations
6.
Schaumberg, Debra A., et al.. (2005). Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial. ACC Current Journal Review. 14(9). 7–8. 1 indexed citations
7.
Kurth, Tobias, et al.. (2005). Alcohol consumption and the risk of renal dysfunction in apparently healthy men. University of Groningen research database (University of Groningen / Centre for Information Technology). 165(9). 1048–1053. 2 indexed citations
8.
Gage, Brian F., Charles S. Eby, Julie A. Johnson, et al.. (2005). Use of Pharmacogenetics and Clinical Factors To Predict the Maintenance Dose of Warfarin.. Blood. 106(11). 550–550. 17 indexed citations
9.
Kurth, Tobias, et al.. (2003). Alcohol and the risk of renal dysfunction in apparently healthy men.. Journal of the American Society of Nephrology. 14. 1 indexed citations
10.
Christen, William G., JoAnn E. Manson, RJ Glynn, et al.. (2003). A RANDOMIZED TRIAL OF BETA CAROTENE AND AGE-RELATED CATARACT IN U.S. PHYSICIANS. Evidence-Based Eye Care. 4(3). 146–147. 1 indexed citations
12.
Glynn, RJ, et al.. (1999). Agreement between Drug Treatment Data and a Discharge Diagnosis of Diabetes Mellitus in the Elderly. American Journal of Epidemiology. 149(6). 541–549. 37 indexed citations
13.
Christen, William G., Umed A. Ajani, RJ Glynn, et al.. (1999). Prospective Cohort Study of Antioxidant Vitamin Supplement Use and the Risk of Age-related Maculopathy. American Journal of Epidemiology. 149(5). 476–484. 50 indexed citations
14.
Glynn, RJ, et al.. (1997). A prospective study of cigarette smoking and risk of age-related macular degeneration in men.. American Journal of Ophthalmology. 123(1). 149–149. 49 indexed citations
15.
Monane, Mark, Rhonda L. Bohn, Jerry H. Gurwitz, et al.. (1996). Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race.. American Journal of Public Health. 86(12). 1805–1808. 206 indexed citations
16.
Gurwitz, Jerry H., Daniel E. Everitt, Mark Monane, et al.. (1996). The Impact of Ibuprofen on the Efficacy of Antihypertensive Treatment With Hydrochlorothiazide in Elderly Persons. The Journals of Gerontology Series A. 51A(2). M74–M79. 30 indexed citations
17.
Manson, JoAnn E., J.M. Seddon, RJ Glynn, et al.. (1993). A prospective study of cigarette smoking and risk of cataract in men. Journal of Safety Research. 24(2). 129–130. 14 indexed citations
18.
Glynn, RJ, et al.. (1992). Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study.. Journal of Studies on Alcohol. 53(1). 25–32. 115 indexed citations
19.
Glynn, RJ, et al.. (1988). ALCOHOL CONSUMPTION, TYPE A BEHAVIOR, AND DEMOGRAPHIC VARIABLES. American Journal of Epidemiology. 127(2). 310–320. 13 indexed citations
20.
Glynn, RJ, et al.. (1986). Selection modelling versus mixture modelling with nonignorable nonresponse. 115–142. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026